| Pharmaceutical active ingredients: |
| Iothalamate Sodium, I-125 |
| Available forms, composition and doses of Glofil: |
| Injectable; Injection; Iothalamate Sodium, I-125 250-300 UCI / ml |
| Glofil medical category: |
| Human:Roentgenography |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| V09CX03 - Sodium iothalamate (125I) |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Questcor Pharmaceuticals |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Conray | Iothalamate Meglumine | Mallinckrodt; Bracco; Humana; Tyco Healthcare |
| Cysto Conray | Iothalamate Meglumine | Mallinckrodt; Tyco Healthcare |
| Cysto-Conray II | Iothalamate Meglumine | Mallinckrodt |
| Vascoray | Iothalamate Meglumine; Iothalamate Sodium | Mallinckrodt; Rovi Laboratorios; Tyco Healthcare |
| Angio-Conray | Iothalamate Sodium | Mallinckrodt; Bracco |
| Iotrovist | Iotrolan | Bayer Schering Pharma |
| Hexabrix | Ioxaglate Meglumine; Ioxaglate Sodium | Guerbet; A. Martins & Fernandes; Codali; Gothia Medical; In Vitro Technologies; Mallinckrodt; ProMedico; R + N Farmakevtika; Rider Laboratorios; Sanofi-Aventis; Temis Lostalo Laboratorios; Tyco Healthcare; WL-Medical |
| Hexabrix 200 | Ioxaglate Meglumine; Ioxaglate Sodium | Guerbet; Rider Laboratorios; Tyco Healthcare |
| Hexabrix 320 | Ioxaglate Meglumine; Ioxaglate Sodium | Guerbet; Rider Laboratorios; Tyco Healthcare |
| Hexabrix 160 | Ioxaglic Acid | Guerbet; Rider Laboratorios; Tyco Healthcare |